FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.16  |  FHIR Version n/a  User: [n/a]

FHIR IG Statistics (219 ms)

Resources - All Kinds, Realm EU, Authority Hl7, Version R4

726 resources

Type:
Text: Use quotation marks (") for an exact phrase. You can use AND, OR, and NOT. Wildcard = *

Rows 0 - 200 Next
PackageIdentityName/TitleStatusDate
hl7.eu.fhir.xshare-ybImplementationGuide/hl7.eu.fhir.xshare-yb xShare Project Yellow Buttonactive2025-04
hl7.eu.fhir.xshare-ybCapabilityStatement/capabilityStatement-yb-consumer xShare Yellow Button Consumer Capability Statementdraft2025-04
hl7.eu.fhir.xshare-ybCapabilityStatement/capabilityStatement-yb-provider xShare Yellow Button Provider Capability Statementdraft2025-04
hl7.eu.fhir.fluteTestScript/TS-Flute-01 Study Inclusion Criteria - Scenario 01draft2025-04
hl7.eu.fhir.fluteTestScript/TS-Flute-02 Study Inclusion Criteria - Scenario 02draft2025-04
hl7.eu.fhir.fluteTestScript/TS-Flute-03 This TestScript is designed to validate the populate of a questionnairedraft2024-05
hl7.eu.fhir.fluteTestScript/TS-Flute-04 This TestScript is designed to validate the extract of a questionnaire responsedraft2024-05
hl7.eu.fhir.fluteTestScript/TS-Flute-05 This TestScript is designed to validate the cql library ResearchVariables2draft2024-06
hl7.eu.fhir.fluteQuestionnaire/Questionnaire-StudyVariable Study variable Extractionactive2024-03
hl7.eu.fhir.fluteImplementationGuide/hl7.eu.fhir.flute FLUTE Cross-border Prostate Cancer Data Standard Guidedraft2025-04
hl7.eu.fhir.fluteStructureDefinition/LM-InclusionCriterias Inclusion Criteria for Prostate Cancer Cohortsdraft2025-04
hl7.eu.fhir.fluteStructureDefinition/LM-StudyVariables Prostate Cancer study Variablesdraft2025-04
hl7.eu.fhir.fluteStructureDefinition/PR-Biopsy Procedure: biopsydraft2025-04
hl7.eu.fhir.fluteStructureDefinition/PR-DigitalRectalExamination Procedure: DREdraft2025-04
hl7.eu.fhir.fluteStructureDefinition/PR-OutcomeBCN-RC2 Observation: Outcome BCN-RC 2draft2025-04
hl7.eu.fhir.fluteStructureDefinition/PR-PIRADSScore Observation: PI-RADSdraft2025-04
hl7.eu.fhir.fluteStructureDefinition/PR-ProstateCancerFamilyHistory FamilyMemberHistory: prostate cancer family historydraft2025-04
hl7.eu.fhir.fluteStructureDefinition/PR-ProstateSpecificAntigen Observation: prostate specific antigendraft2025-04
hl7.eu.fhir.fluteStructureDefinition/PR-ProstateVolume Observation: prostate volumedraft2025-04
hl7.eu.fhir.fluteStructureDefinition/documentReference-eu-flute DocumentReference: link with variablesdraft2025-04
hl7.eu.fhir.fluteStructureDefinition/imagingStudy-eu-flute ImagingStudy: link with variablesdraft2025-04
hl7.eu.fhir.fluteStructureDefinition/resource-supportingInfo Resource supporting informationdraft2025-04
hl7.eu.fhir.fluteConceptMap/CM-Requirements2StudyVariables Requirements to Study variables Model Mapdraft2023-12
hl7.eu.fhir.fluteConceptMap/CM-StudyVariables2FHIR Study variables Model to FHIR R4 Mapdraft2023-12
hl7.eu.fhir.fluteConceptMap/InclusionCriterias2FHIR Concept Map for Inclusion Criteria to FHIRdraft2024-05
hl7.eu.fhir.fluteConceptMap/Requirements2StudyVariables Requirements to Study variables Model Mapdraft2023-12
hl7.eu.fhir.fluteValueSet/VS-BiopsyType Type of Biopsydraft2025-04
hl7.eu.fhir.fluteValueSet/VS-DREOutcomeCode DRE Observation Interpretation Codesdraft2025-04
hl7.eu.fhir.fluteValueSet/VS-GleasonGrade Gleason Gradedraft2025-04
hl7.eu.fhir.fluteValueSet/VS-PCa Malignant tumor of prostate Value Setdraft2025-04
hl7.eu.fhir.fluteValueSet/VS-PiRads Prostate Imaging – Reporting and Data Systemdraft2025-04
hl7.fhir.eu.epsImplementationGuide/hl7.fhir.eu.eps HL7 Europe Patient Summarydraft2025-06
hl7.fhir.eu.epsStructureDefinition/Allergy A.2.1.1 - Allergydraft2025-06
hl7.fhir.eu.epsStructureDefinition/ClosedProblem A.2.2.2 - Resolved, closed or inactive problemsdraft2025-06
hl7.fhir.eu.epsStructureDefinition/FunctionalStatus A.2.3.3 - Functional Statusdraft2025-06
hl7.fhir.eu.epsStructureDefinition/MedicalDevice A.2.3.2 - Medical devices and implantsdraft2025-06
hl7.fhir.eu.epsStructureDefinition/Medication-eu-eps Medication (EPS)draft2025-06
hl7.fhir.eu.epsStructureDefinition/MedicationStatement-eu-eps Medication Statement (EPS)draft2025-06
hl7.fhir.eu.epsStructureDefinition/Medicine A.2.4.1 Current and relevant past medicinesdraft2025-06
hl7.fhir.eu.epsStructureDefinition/PatientSummary A - Patient Summarydraft2025-06
hl7.fhir.eu.epsStructureDefinition/Pregnancy A.2.6 Pregnancy historydraft2025-06
hl7.fhir.eu.epsStructureDefinition/Problem A.2.3.1 Current problemsdraft2025-06
hl7.fhir.eu.epsStructureDefinition/ProcedurePs A.2.3.3 - Proceduresdraft2025-06
hl7.fhir.eu.epsStructureDefinition/Result A.2.8 - Resultsdraft2025-06
hl7.fhir.eu.epsStructureDefinition/Subject A1.1, A1.2 - Subject of caredraft2025-06
hl7.fhir.eu.epsStructureDefinition/Vaccination A.2.2.1 - Vaccination/ prophylaxis informationdraft2025-06
hl7.fhir.eu.epsStructureDefinition/allergyIntolerance-eu-eps Allergy Intolerance (EPS)draft2025-06
hl7.fhir.eu.epsStructureDefinition/bundle-eu-eps Bundle (EPS)draft2025-06
hl7.fhir.eu.epsStructureDefinition/composition-eu-eps Composition (EPS)draft2025-06
hl7.fhir.eu.epsStructureDefinition/condition-eu-eps Condition (EPS)draft2025-06
hl7.fhir.eu.epsStructureDefinition/condition-statusReason Condition Status Reasondraft2025-06
hl7.fhir.eu.epsStructureDefinition/consent-eu-eps Consent (Advance Directives EPS)draft2025-06
hl7.fhir.eu.epsStructureDefinition/device-eu-eps Device (EPS)draft2025-06
hl7.fhir.eu.epsStructureDefinition/deviceUseStatement-eu-eps DeviceUseStatement (EPS)draft2025-06
hl7.fhir.eu.epsStructureDefinition/flag-eu-eps Flag (EPS)draft2025-06
hl7.fhir.eu.epsStructureDefinition/immunization-administeredProduct Immunization AdministeredProductdraft2025-06
hl7.fhir.eu.epsStructureDefinition/immunization-eu-eps Immunization (EPS)draft2025-06
hl7.fhir.eu.epsStructureDefinition/immunizationRecommendation-eu-eps ImmunizationRecommendation (EPS)draft2025-06
hl7.fhir.eu.epsStructureDefinition/medicationAdministration-eu-eps MedicationAdministration (EPS)draft2025-06
hl7.fhir.eu.epsStructureDefinition/medicationDispense-eu-eps MedicationDispense (EPS)draft2025-06
hl7.fhir.eu.epsStructureDefinition/medicationRequest-eu-eps MedicationRequest (EPS)draft2025-06
hl7.fhir.eu.epsStructureDefinition/observation-travel-eu-eps Observation: country visited (EPS)draft2025-06
hl7.fhir.eu.epsStructureDefinition/patient-eu-eps Patient (EPS)draft2025-06
hl7.fhir.eu.epsStructureDefinition/procedure-eu-eps Procedure (EPS)draft2025-06
hl7.fhir.eu.epsStructureDefinition/supportingInformation Supporting Informationdraft2025-06
hl7.fhir.eu.epsConceptMap/patientSummary2FHIR eHN Patient Summary to this guide Mapdraft2025-06
hl7.fhir.eu.epsConceptMap/subjectPs2FHIR eHN Subject to this guide Mapdraft2025-06
hl7.fhir.eu.epshttp://hl7.eu/fhir/hdr/ConceptMap/vaccination2FHIR-eu-eps eHN Alerts Model to this guide Mapdraft2025-06
hl7.fhir.eu.epshttp://terminology.ehdsi.eu/ValueSet/eHDSISeverity Severityactive2025-06
hl7.fhir.eu.epsValueSet/medical-devices-eu-hdr Medical Devices (SNOMED CT)draft2025-06
hl7.fhir.eu.epsValueSet/medical-devices-snomed-absent-unknown-eu-hdr Medical Devices - SNOMED CT + Absent/Unknown - IPSdraft2025-06
hl7.eu.fhir.coalescedImplementationGuide/hl7.eu.fhir.coalesced CoalescedImplementationGuidedraft2025-06
hl7.eu.fhir.coalescedStructureDefinition/combined-european-patient-profile Combined European Patient Profile.draft2025-06
hl7.eu.fhir.xshare-ipsrImplementationGuide/hl7.eu.fhir.xshare-ipsr xShare Project IPS+Rdraft2025-05
hl7.eu.fhir.idea4rcImplementationGuide/hl7.eu.fhir.idea4rc IDEA4RC FHIR Implementation Guidedraft2025-06
hl7.eu.fhir.idea4rcStructureDefinition/AdverseEvent Adverse Eventdraft2025-06
hl7.eu.fhir.idea4rcStructureDefinition/Bundle-eu-i4rc Bundle: IDEA4RCdraft2025-06
hl7.eu.fhir.idea4rcStructureDefinition/CancerEpisode Cancer Episodedraft2025-06
hl7.eu.fhir.idea4rcStructureDefinition/ClinicalStage Clinical Stagedraft2025-06
hl7.eu.fhir.idea4rcStructureDefinition/Condition-primaryCancer-eu-i4rc Condition: Primary Cancerdraft2025-06
hl7.eu.fhir.idea4rcStructureDefinition/Condition-secondaryCancer-eu-i4rc Condition: Metastatic Cancerdraft2025-06
hl7.eu.fhir.idea4rcStructureDefinition/Diagnosis Diagnosisdraft2025-06
hl7.eu.fhir.idea4rcStructureDefinition/DiseaseExtent Disease Extentdraft2025-06
hl7.eu.fhir.idea4rcStructureDefinition/DrugsForTreatments Drugs for Treatmentsdraft2025-06
hl7.eu.fhir.idea4rcStructureDefinition/Encounter-eu-i4rc Encounter: IDEA4RCdraft2025-06
hl7.eu.fhir.idea4rcStructureDefinition/EpisodeEvent Episode Eventdraft2025-06
hl7.eu.fhir.idea4rcStructureDefinition/GeneticTestExpression Genetic Test Expressiondraft2025-06
hl7.eu.fhir.idea4rcStructureDefinition/HospitalPatientRecords Hospital Patient Records and Hospital Datadraft2025-06
hl7.eu.fhir.idea4rcStructureDefinition/IsolatedLimbPerfusion Isolated Limb Perfusiondraft2025-06
hl7.eu.fhir.idea4rcStructureDefinition/MedicationAdministration-eu-i4rc MedicationAdministration: Chemotherapydraft2025-06
hl7.eu.fhir.idea4rcStructureDefinition/Observation-diagnosis-eu-i4rc Observation: Diagnosis detailsdraft2025-06
hl7.eu.fhir.idea4rcStructureDefinition/OverallTreatmentResponse Overall Treatment Responsedraft2025-06
hl7.eu.fhir.idea4rcStructureDefinition/PathologicalStage Pathological Stagedraft2025-06
hl7.eu.fhir.idea4rcStructureDefinition/PatientFollowUp Patient Follow Updraft2025-06
hl7.eu.fhir.idea4rcStructureDefinition/Procedure-otherTreatment-eu-i4rc Procedure: Other Treatmentdraft2025-06
hl7.eu.fhir.idea4rcStructureDefinition/Procedure-radiotheraphy-eu-i4rc Procedure: Radiotherapydraft2025-06
hl7.eu.fhir.idea4rcStructureDefinition/Procedure-surgery-eu-i4rc Procedure: Surgerydraft2025-06
hl7.eu.fhir.idea4rcStructureDefinition/Race-eu-i4rc Race Extensiondraft2025-06
hl7.eu.fhir.idea4rcStructureDefinition/Radiotherapy Radiotherapydraft2025-06
hl7.eu.fhir.idea4rcStructureDefinition/RegionalDeepHyperthemia Regional Deep Hyperthemiadraft2025-06
hl7.eu.fhir.idea4rcStructureDefinition/Subject Patientdraft2025-06
hl7.eu.fhir.idea4rcStructureDefinition/Substance-otherTreatment-eu-i4rc Substance : Other Treatmentdraft2025-06
hl7.eu.fhir.idea4rcStructureDefinition/Surgery Surgerydraft2025-06
hl7.eu.fhir.idea4rcStructureDefinition/SystemicTreatment Systemic Treatmentdraft2025-06
hl7.eu.fhir.idea4rcStructureDefinition/adverseEvent-eu-i4rc AdverseEvent: IDEA4RCdraft2025-06
hl7.eu.fhir.idea4rcStructureDefinition/condition-histology-morphology-behavior Histology Morphology Behaviordraft2025-06
hl7.eu.fhir.idea4rcStructureDefinition/condition-previousStatus Previous Statusdraft2025-06
hl7.eu.fhir.idea4rcStructureDefinition/condition-relapseType Relapse Typedraft2025-06
hl7.eu.fhir.idea4rcStructureDefinition/episodeOfCare-eu-i4rc EpisodeOfCare: IDEA4RCdraft2025-06
hl7.eu.fhir.idea4rcStructureDefinition/hn-cancer-stage-group Observation: Head Neck Cancer Stage Groupdraft2025-06
hl7.eu.fhir.idea4rcStructureDefinition/mcode-body-location-qualifier Body Location Qualifierdraft2025-06
hl7.eu.fhir.idea4rcStructureDefinition/mcode-condition-related Condition related to resourcedraft2025-06
hl7.eu.fhir.idea4rcStructureDefinition/mcode-laterality-qualifier Laterality Qualifierdraft2025-06
hl7.eu.fhir.idea4rcStructureDefinition/mcode-radiotherapy-dose-delivered-to-volume Radiotherapy Dose Delivered To Volume Extensiondraft2025-06
hl7.eu.fhir.idea4rcStructureDefinition/mcode-radiotherapy-modality-and-technique Radiotherapy Modality And Technique Extensiondraft2025-06
hl7.eu.fhir.idea4rcStructureDefinition/mcode-radiotherapy-modality Radiotherapy Modality Extensiondraft2025-06
hl7.eu.fhir.idea4rcStructureDefinition/mcode-radiotherapy-sessions Radiotherapy Number of Sessions Extensiondraft2025-06
hl7.eu.fhir.idea4rcStructureDefinition/mcode-radiotherapy-technique Radiotherapy Technique Extensiondraft2025-06
hl7.eu.fhir.idea4rcStructureDefinition/mcode-tnm-distant-metastases-category Observation: TNM Distant Metastases Categorydraft2025-06
hl7.eu.fhir.idea4rcStructureDefinition/mcode-tnm-primary-tumor-category Observation: TNM Primary Tumor Categorydraft2025-06
hl7.eu.fhir.idea4rcStructureDefinition/mcode-tnm-regional-nodes-category Observation: TNM Regional Nodes Categorydraft2025-06
hl7.eu.fhir.idea4rcStructureDefinition/observation-alcoholuse-eu-i4rc Observation: Alcohol usedraft2025-06
hl7.eu.fhir.idea4rcStructureDefinition/observation-cci-eu-i4rc Observation: Charlson Comorbidity Indexdraft2025-06
hl7.eu.fhir.idea4rcStructureDefinition/observation-comorbidity-eu-i4rc Observation: Comorbiditiesdraft2025-06
hl7.eu.fhir.idea4rcStructureDefinition/observation-dateLastContact-eu-i4rc Observation: date of the last contactdraft2025-06
hl7.eu.fhir.idea4rcStructureDefinition/observation-ecog-performance-status-eu-i4rc Observation: ECOG Performance Statusdraft2025-06
hl7.eu.fhir.idea4rcStructureDefinition/observation-extraNodalExtension-eu-i4rc Observation: Radiological Extra-nodal extension (rENE)draft2025-06
hl7.eu.fhir.idea4rcStructureDefinition/observation-karnofsky-performance-status-eu-i4rc Observation: Karnofsky Performance Statusdraft2025-06
hl7.eu.fhir.idea4rcStructureDefinition/observation-lastFollowupStatus-eu-i4rc Observation: Status at the Last Follow Updraft2025-06
hl7.eu.fhir.idea4rcStructureDefinition/observation-occurrencOtherCancer-eu-i4rc Observation: Occurrence of the other cancerdraft2025-06
hl7.eu.fhir.idea4rcStructureDefinition/observation-overallTreatment-eu-i4rc Observation: Overall Treatmentdraft2025-06
hl7.eu.fhir.idea4rcStructureDefinition/observation-testResult-eu-i4rc Observation: test resultsdraft2025-06
hl7.eu.fhir.idea4rcStructureDefinition/observation-tobaccouse-eu-i4rc Observation: Tobacco usedraft2025-06
hl7.eu.fhir.idea4rcStructureDefinition/observation-treatment-eu-i4rc Observation: Cancer Treatmentdraft2025-06
hl7.eu.fhir.idea4rcStructureDefinition/observation-yesNo-eu-i4rc Observation: Yes / No assertionsdraft2025-06
hl7.eu.fhir.idea4rcStructureDefinition/patient-eu-i4rc Patient: IDEA4RCdraft2025-06
hl7.eu.fhir.idea4rcStructureDefinition/procedure-performedTiming Performed Timingdraft2025-06
hl7.eu.fhir.idea4rcStructureDefinition/radiotherapy-energy-or-isotope Radiotherapy Energy or Isotopedraft2025-06
hl7.eu.fhir.idea4rcStructureDefinition/same-custodian-flag Same custodian flagdraft2025-06
hl7.eu.fhir.idea4rcStructureDefinition/same-hospital Same Hospitaldraft2025-06
hl7.eu.fhir.idea4rcStructureDefinition/sarcoma-cancer-stage-group Observation: Sarcoma Cancer and Disease Extent Stage Groupdraft2025-06
hl7.eu.fhir.idea4rcStructureDefinition/sarcoma-extent-category Observation: Localized Category (Stage, Sarcoma)draft2025-06
hl7.eu.fhir.idea4rcStructureDefinition/sarcoma-locoRegional-category Observation: LocoRegional Category (Stage, Sarcoma)draft2025-06
hl7.eu.fhir.idea4rcConceptMap/adverseEvent2FHIR Radiotherapy Model to this guide Mapdraft2025-06
hl7.eu.fhir.idea4rcConceptMap/cancerEpisode2FHIR CancerEpisod Model to this guide Mapdraft2025-06
hl7.eu.fhir.idea4rcConceptMap/diagnosis2FHIR Diagnosis Model to this guide Mapdraft2025-06
hl7.eu.fhir.idea4rcConceptMap/episodeEvent2FHIR Episode Event Model to this guide Mapdraft2025-06
hl7.eu.fhir.idea4rcConceptMap/followup2FHIR Patient Follow up Model to this guide Mapdraft2025-06
hl7.eu.fhir.idea4rcConceptMap/geneticTest2FHIR Genetic Test to this guide Mapdraft2025-06
hl7.eu.fhir.idea4rcConceptMap/geneticTestExpression2FHIR Genetic Test Expression Model to this guide Mapdraft2025-06
hl7.eu.fhir.idea4rcConceptMap/hNstage2FHIR HN Stage Model to this guide Mapdraft2025-06
hl7.eu.fhir.idea4rcConceptMap/hospitalPatientRecords2FHIR Hospital Patient Records Model to this guide Mapdraft2025-06
hl7.eu.fhir.idea4rcConceptMap/otherTreatment2FHIR Other Treatment to this guide Mapdraft2025-06
hl7.eu.fhir.idea4rcConceptMap/radiotherapy2FHIR Radiotherapy Model to this guide Mapdraft2025-06
hl7.eu.fhir.idea4rcConceptMap/sarcomaStage2FHIR Stage Model to this guide Mapdraft2025-06
hl7.eu.fhir.idea4rcConceptMap/subject2FHIR Subject Model to this guide Mapdraft2025-06
hl7.eu.fhir.idea4rcConceptMap/surgery2FHIR Surgery Model to this guide Mapdraft2025-06
hl7.eu.fhir.idea4rcValueSet/Gender-i4rc Gender: Athenaactive2025-06
hl7.eu.fhir.idea4rcValueSet/HNC-condition-athena-vs HNC ConditionList: Athenadraft2025-06
hl7.eu.fhir.idea4rcValueSet/alcoholUsageStatus-athena-eu-i4rc Alcohol Usage Status: Athenaactive2025-06
hl7.eu.fhir.idea4rcValueSet/alcoholUsageStatus-snomed-eu-i4rc Alcohol Usage Status: SNOMED CTactive2025-06
hl7.eu.fhir.idea4rcValueSet/beam-quality-i4rc Beam Qualityactive2025-06
hl7.eu.fhir.idea4rcValueSet/cancer-diagnosis-athena-vs Cancer Diagnosis: Athenadraft2025-06
hl7.eu.fhir.idea4rcValueSet/cancer-event-type-vs Disease Status: Athenadraft2025-06
hl7.eu.fhir.idea4rcValueSet/cancer-histology-athena-vs Cancer histology: Athenadraft2025-06
hl7.eu.fhir.idea4rcValueSet/cancer-histology-behavior-athena-vs Cancer histology behaviour: Athenadraft2025-06
hl7.eu.fhir.idea4rcValueSet/cancer-histology-subgroup-athena-vs Cancer histology subgroup: Athenadraft2025-06
hl7.eu.fhir.idea4rcValueSet/cancer-stageGrading-athena-vs Cancer Stage Grading: Athenadraft2025-06
hl7.eu.fhir.idea4rcValueSet/cancer-stageGroup-athena-vs Cancer Stage Group: Athenadraft2025-06
hl7.eu.fhir.idea4rcValueSet/cancer-stageGroupValue-athena-vs Cancer Stage Group Value: Athenadraft2025-06
hl7.eu.fhir.idea4rcValueSet/chemo-units-eu-i4rc Chemotherapy cumulative dose unitsdraft2025-06
hl7.eu.fhir.idea4rcValueSet/coded-test-results-athena-vs Coded test results: Athena.draft2025-06
hl7.eu.fhir.idea4rcValueSet/comorbidities-athena-eu-i4rc Comorbidities: Athenaactive2025-06
hl7.eu.fhir.idea4rcValueSet/comorbidities-sct-eu-i4rc Comorbidities: SNOMEDactive2025-06
hl7.eu.fhir.idea4rcValueSet/country-eu-i4rc Country: athenaactive2025-06
hl7.eu.fhir.idea4rcValueSet/disease-extent-category-vs Sarcoma Staging: localized diseasedraft2025-06
hl7.eu.fhir.idea4rcValueSet/drug-for-treatments-eu-i4rc Drugs for Treatmentsdraft2025-06
hl7.eu.fhir.idea4rcValueSet/drug-systemic-treatments-eu-i4rc Drugs for Systemic Treatmentdraft2025-06
hl7.eu.fhir.idea4rcValueSet/drugsAtc-eu-i4rc Antineoplastic and immunostimulating agentsdraft2025-06
hl7.eu.fhir.idea4rcValueSet/ecog-i4rc ECOG Performance Statusactive2025-06
hl7.eu.fhir.idea4rcValueSet/event-type-eu-i4rc Event Typeactive2025-06
hl7.eu.fhir.idea4rcValueSet/extranodal-extension-i4rc Extranodal Extensiondraft2025-06
hl7.eu.fhir.idea4rcValueSet/geneticTestPerformed-eu-i4rc Genetic Tests performed (Yes/no/Unk)active2025-06
hl7.eu.fhir.idea4rcValueSet/genito-urinary-subsite-athena-i4rc Genito urinary subsite: Athenaactive2025-06
hl7.eu.fhir.idea4rcValueSet/hypopharynx-subsite-athena-i4rc Hypopharynx subsite: Athenaactive2025-06
hl7.eu.fhir.idea4rcValueSet/hypopharynx-subsite-sct-i4rc Hypopharynx subsite: Snomed CTactive2025-06
hl7.eu.fhir.idea4rcValueSet/intra-abdominal-subsite-athena-i4rc Intra abdominal subsite: Athenaactive2025-06
hl7.eu.fhir.idea4rcValueSet/intra-thoracic-subsite-athena-i4rc Intra thoracic subsite : Athenaactive2025-06
hl7.eu.fhir.idea4rcValueSet/larynx-subsite-athena-i4rc Larynx subsite: Athenaactive2025-06
hl7.eu.fhir.idea4rcValueSet/larynx-subsite-sct-i4rc Larynx subsite: Snomed CTactive2025-06
hl7.eu.fhir.idea4rcValueSet/lip-subsite-athena-i4rc Lip subsite: Athenaactive2025-06
hl7.eu.fhir.idea4rcValueSet/lip-subsite-sct-i4rc Lip subsite: Snomed CTactive2025-06
hl7.eu.fhir.idea4rcValueSet/locoregional-category-vs Sarcoma Staging: loco-regional categorydraft2025-06
hl7.eu.fhir.idea4rcValueSet/margins-after-surgery-eu-i4rc Margins After Surgeryactive2025-06
hl7.eu.fhir.idea4rcValueSet/mcode-observation-codes-distant-metastases-vs Observation Codes for Distant Metastases Categorydraft2025-06
hl7.eu.fhir.idea4rcValueSet/mcode-observation-codes-primary-tumor-vs Observation Codes for Primary Tumor Categorydraft2025-06
hl7.eu.fhir.idea4rcValueSet/mcode-observation-codes-regional-nodes-vs Observation Codes for Regional Node Categorydraft2025-06
hl7.eu.fhir.idea4rcValueSet/mcode-tnm-distant-metastases-category-vs TNM Distant Metastases Category Value Setdraft2025-06
hl7.eu.fhir.idea4rcValueSet/mcode-tnm-primary-tumor-category-vs TNM Primary Tumor Category Value Setdraft2025-06
hl7.eu.fhir.idea4rcValueSet/mcode-tnm-regional-nodes-category-vs TNM Regional Nodes Category Value Setdraft2025-06

XIG built as of 29 Jun 2025. Found 77614 resources in 1242 packages.